Rare diseases
Investigational molecules
Locations
Back to Germany146 clinical trials in Bielefeld, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on PRAX-628 for Adults with Focal Onset or Generalized Tonic-Clonic Seizures
GermanyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
GermanyStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
GermanyStudy on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
GermanyStudy on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder
GermanyStudy on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma
GermanyStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
GermanyStudy on the Safety and Effectiveness of Azetukalner for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
GermanyStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
GermanyStudy on Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed High-Risk Multiple Myeloma Patients
GermanyStudy on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder
GermanyStudy Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on breast cancer treatments, including innovative therapies for HR-positive and HER2-negative variants. Research extends to gastric cancer and advanced ovarian cancer treatments.
Novel combinations of targeted therapies and immunotherapies are being evaluated for improved patient outcomes.
Comprehensive research into epilepsy and seizure disorders, with particular focus on both focal onset and generalized seizures. Studies include investigations of new treatments for Dravet Syndrome.
Emphasis on developing long-term treatment solutions for various seizure types.
Investigation of treatments for plaque psoriasis and preventive measures for atopic dermatitis in high-risk populations. Focus on both adult and pediatric patients.
Studies aim to develop effective management strategies for chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
